FDA NDC Directory · JSON-LD · Markdown

Buspirone Hydrochloride

NDC 0093-5200 · HUMAN PRESCRIPTION DRUG · TABLET

Labeler / ManufacturerTeva Pharmaceuticals USA, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA075022
Dosage form / routeTABLET · ORAL
Active ingredientsBUSPIRONE HYDROCHLORIDE (30 mg/1)
Marketing started20040326
Package count2

External sources

Source: openFDA. Public-domain (CC0).